Steinmetz JD, Culbreth GT, Haile LM, et al. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(9):e508–22. https://doi.org/10.1016/S2665-9913(23)00163-7.
Batushansky A, Zhu S, Komaravolu RK, South S, Mehta-D’souza P, Griffin TM. Fundamentals of OA. An initiative of osteoarthritis and cartilage. Obesity and metabolic factors in OA. Osteoarthritis Cartilage. 2022;30(4):501–15. https://doi.org/10.1016/j.joca.2021.06.013.
Article CAS PubMed Google Scholar
Jenei-Lanzl Z, Meurer A, Zaucke F. Interleukin-1β signaling in osteoarthritis—chondrocytes in focus. Cell Signal. 2019. https://doi.org/10.1016/j.cellsig.2018.10.005.
Sampath SJP, Venkatesan V, Ghosh S, Kotikalapudi N. Obesity, metabolic syndrome, and osteoarthritis—an updated review. Curr Obes Rep. 2023;12(3):308–31. https://doi.org/10.1007/s13679-023-00520-5.
Hodgkinson T, Kelly DC, Curtin CM, O’Brien FJ. Mechanosignalling in cartilage: an emerging target for the treatment of osteoarthritis. Nat Rev Rheumatol. 2022;18(2):67–84. https://doi.org/10.1038/s41584-021-00724-w.
Reyes C, Leyland KM, Peat G, Cooper C, Arden NK, Prieto-Alhambra D. Association between overweight and obesity and risk of clinically diagnosed knee, hip, and hand osteoarthritis: a population-based cohort study. Arthritis Rheumatol. 2016;68(8):1869–75. https://doi.org/10.1002/art.39707.
Article PubMed PubMed Central Google Scholar
Dell’Isola A, Allan R, Smith SL, Marreiros SSP, Steultjens M. Identification of clinical phenotypes in knee osteoarthritis: a systematic review of the literature. BMC Musculoskelet Disord. 2016;17(1):425. https://doi.org/10.1186/s12891-016-1286-2.
Article CAS PubMed PubMed Central Google Scholar
Damerau A, Rosenow E, Alkhoury D, Buttgereit F, Gaber T. Fibrotic pathways and fibroblast-like synoviocyte phenotypes in osteoarthritis. Front Immunol. 2024. https://doi.org/10.3389/fimmu.2024.1385006.
Article PubMed PubMed Central Google Scholar
Choi WS, Lee G, Song WH, et al. The CH25H–CYP7B1–RORα axis of cholesterol metabolism regulates osteoarthritis. Nature. 2019;566(7743):254–8. https://doi.org/10.1038/s41586-019-0920-1.
Article CAS PubMed Google Scholar
Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020;72(2):220–33. https://doi.org/10.1002/art.41142.
Article PubMed PubMed Central Google Scholar
Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578–89. https://doi.org/10.1016/j.joca.2019.06.011.
Article CAS PubMed Google Scholar
Hirsch G, Kitas G, Klocke R. Intra-articular corticosteroid injection in osteoarthritis of the knee and hip: factors predicting pain relief—a systematic review. Semin Arthritis Rheum. 2013. https://doi.org/10.1016/j.semarthrit.2012.08.005.
Osteoarthritis in over 16s: diagnosis and management. London: National Institute for Health and Care Excellence (NICE); October 19, 2022. October 2022. Accessed August 18, 2025. https://www.nice.org.uk/guidance/ng226
Hartmann K, Koenen M, Schauer S, et al. Molecular actions of glucocorticoids in cartilage and bone during health, disease, and steroid therapy. Physiol Rev. 2016;96(2):409–47. https://doi.org/10.1152/physrev.00011.2015.
Article CAS PubMed Google Scholar
Catley MC. Dissociated Steroids. Sci World J. 2007;7:421–30. https://doi.org/10.1100/tsw.2007.97.
Pemmari A, Leppänen T, Hämäläinen M, Moilanen T, Vuolteenaho K, Moilanen E. Widespread regulation of gene expression by glucocorticoids in chondrocytes from patients with osteoarthritis as determined by RNA-Seq. Arthritis Res Ther. 2020. https://doi.org/10.1186/s13075-020-02289-7.
Article PubMed PubMed Central Google Scholar
Pemmari A, Paukkeri E, Hämäläinen M, Leppänen T, Korhonen R, Moilanen E. MKP-1 promotes anti-inflammatory m(IL-4/IL-13) macrophage phenotype and mediates the anti-inflammatory effects of glucocorticoids. Basic Clin Pharmacol Toxicol. 2019;124(4):404. https://doi.org/10.1111/bcpt.13163.
Article CAS PubMed Google Scholar
Lehtola T, Nummenmaa E, Tuure L, et al. Dexamethasone attenuates the expression of MMP-13 in chondrocytes through MKP-1. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms23073880.
Article PubMed PubMed Central Google Scholar
Kirk SG, Samavati L, Liu Y. MAP kinase phosphatase-1, a gatekeeper of the acute innate immune response. Life Sci. 2020. https://doi.org/10.1016/j.lfs.2019.117157.
Hoppstädter J, Ammit AJ. Role of dual-specificity phosphatase 1 in glucocorticoid-driven anti-inflammatory responses. Front Immunol. 2019. https://doi.org/10.3389/fimmu.2019.01446.
Article PubMed PubMed Central Google Scholar
Keränen T, Moilanen E, Korhonen R. Suppression of cytokine production by glucocorticoids is mediated by MKP-1 in human lung epithelial cells. Inflamm Res. 2017. https://doi.org/10.1007/s00011-017-1028-4.
Keränen T, Hömmö T, Hämäläinen M, Moilanen E, Korhonen R. Anti-inflammatory effects of β2-receptor agonists salbutamol and terbutaline are mediated by MKP-1. PLoS ONE. 2016. https://doi.org/10.1371/journal.pone.0148144.
Article PubMed PubMed Central Google Scholar
Korhonen R, Hömmö T, Keränen T, et al. Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1. Br J Pharmacol. 2013. https://doi.org/10.1111/bph.12189.
Article PubMed PubMed Central Google Scholar
Lehtola T, Nummenmaa E, Nieminen R, Hämäläinen M, Vuolteenaho K, Moilanen E. The glucocorticoid dexamethasone alleviates allergic inflammation through a mitogen-activated protein kinase phosphatase-1-dependent mechanism in mice. Basic Clin Pharmacol Toxicol. 2024;134(5):686–94. https://doi.org/10.1111/bcpt.13995.
Article CAS PubMed Google Scholar
Tchen CR, Martins JRS, Paktiawal N, Perelli R, Saklatvala J, Clark AR. Glucocorticoid regulation of mouse and human dual specificity phosphatase 1 (DUSP1) genes. J Biol Chem. 2010;285(4):2642–52. https://doi.org/10.1074/jbc.M109.037309.
Article CAS PubMed Google Scholar
Abraham SM, Lawrence T, Kleiman A, et al. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med. 2006;203(8):1883–9. https://doi.org/10.1084/jem.20060336.
Article CAS PubMed PubMed Central Google Scholar
Soul J, Barter MJ, Little CB, Young DA. OATargets: a knowledge base of genes associated with osteoarthritis joint damage in animals. Ann Rheum Dis. 2021;80(3):376–83. https://doi.org/10.1136/annrheumdis-2020-218344.
Article CAS PubMed Google Scholar
Dorfman K, Carrasco D, Gruda M, Ryan C, Lira SA, Bravo R. Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene. 1996;13(5):925–31.
Nummenmaa E, Hämäläinen M, Pemmari A, et al. Transient receptor potential ankyrin 1 (TRPA1) is involved in upregulating interleukin-6 expression in osteoarthritic chondrocyte models. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms22010087.
Article PubMed PubMed Central Google Scholar
Koskinen A, Juslin S, Nieminen R, Moilanen T, Vuolteenaho K, Moilanen E. Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways. Arthritis Res Ther. 2011.
Comments (0)